Czechia vs Guinea-Bissau: The number of people with susceptibility test result for rifampicin
Czechia
89.51
in 2021
Guinea-Bissau
89.04
in 2021
Czechia rank
68th
Guinea-Bissau rank
70th
The number of people with susceptibility test result for rifampicin over time
- Czechia
- Guinea-Bissau
How they compare
Czechia currently reports 89.51 against 89.04 in Guinea-Bissau, a difference of 0.47.
Across all 5 years both countries report, Czechia has been ahead every year.
Czechia ranks 68th and Guinea-Bissau ranks 70th of 146 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.46 | 1.23 | 85.23 | Czechia |
| 2020s | 87.15 | 73.23 | 13.92 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or Guinea-Bissau?
- Czechia, at 89.51 against 89.04 in Guinea-Bissau as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and Guinea-Bissau?
- 0.47, with Czechia ahead.
- How many years of comparable data are there for Czechia and Guinea-Bissau?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and Guinea-Bissau rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 68th and Guinea-Bissau ranks 70th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.